📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines. (2022)

First Author: Andrews N

Attributed to: Investigation of proven vaccine breakthrough by SARS-CoV-2 variants in established UK healthcare worker cohorts: SIREN consortium & PITCH Plus Pathway funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2115481

PubMed Identifier: 35021002

Publication URI: http://europepmc.org/abstract/MED/35021002

Type: Journal Article/Review

Volume: 386

Parent Publication: The New England journal of medicine

Issue: 4

ISSN: 0028-4793